twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2019
vol. 121
 
Share:
Share:
abstract:
Original paper

Biological Treatment of Chronic Non-infectious Uveitis in the Developmental Age

Anna Niwald
1
,
Mirosława Grałek
1
,
Katarzyna Piasecka
1
,
Ewa Lipiec
1

  1. Oddział Okulistyki Dziecięcej Uniwersyteckiego Centrum Pediatrii im. M. Konopnickiej SP ZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi
Online publish date: 2019/11/18
View full text Get citation
 
PlumX metrics:
Aim
Evaluation of the results of treatment of chronic non-infectious uveitis with biologic agents in children and adolescents.

Materials and Methods
8 children (5 girls, 3 boys) treated with biologics (Humira, Remicade) after previous treatment with first and second therapy lines drugs. Binocular changes were observed in 6 children, monocular changes in 2 children (14 eyes). For the diagnosis of non-infectious uveitis and to evaluate the effects of treatment, the ophthalmic examination and research of the laboratory diagnosis and imaging were used. The average time of biological treatment was 12.8 months.

Results
In the examined group of children the number of relapses of the disease (an average of 0.57) has decreased. Visual acuity has improved in every child (mean V = 0.79). Ocular complications occurred in 4 eyes, general complications in 3 children.

Conclusions
Biological therapy of non-infectious uveitis in children is not causal treatment indeed, focused on the ethological factors. However, it influences the patomechanism of disease, strongly modificating its course thus reducing this symptoms and easing this effects.

keywords:

children, non-infectious uveitis, juvenile idiopathic arthritis, immunosuppression, biologic therapy, side effects

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.